Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Case reports of neuroleptic malignant syndrome suggest dantrolene; leaves open need for controlled efficacy trials.
The neuroleptic malignant syndrome is an uncommon and potentially lethal complication of treatment with antipsychotic medication (1). This syndrome is characterized by severe fever, altered mental status, autonomic instability, and generalized skeletal muscle rigidity. Also, leukocytosis and elevations in creatine kinase may be prominent. To date, treatment has consisted mainly of supportive measures (1-5). Recently, attention has been drawn to the similarity between the neuroleptic malignant syndrome and malignant hyperthermia, a pharmacogenetic disorder of skeletal muscle (1). Patients with malignant hyperthermia are susceptible to an acute, life-threatening, hyperthermic reaction to certain pharmacologic agents (6). Dantrolene sodium has been used successfully
No takes yet. Share an insight, caveat, or question.
David C. May (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: